President & CEO
David Mills is the President & CEO of Dallen Medical Inc., a venture backed orthopedic company. Mr. Mills has approximately 25 years in the industry. Prior to Dallen, David founded Harper & Associates, a healthcare consulting company specializing in start-ups and early stage medical devices. David was also the Director of Business Development Marketing & Sales for American Immuno Tech, developers of the Neptune Waste Management System, which was acquired by the Stryker Corporation and is now a $200M product-line. David was also an Area Director for Denver Biomedical which was acquired by Cardinal Health. David earned a B.S. in Business Administration from Miami University, Oxford, OH in 1984 and is a member of OCTANe, an Orange County Technology and Angel Network.
David will be one of the distinguished speakers at the 8th Annual Life Science Chief Executive Officer Forum.
Why is the 8th Annual Life Science CEO Forum important for C-suite executives?
To stay in tune with the ever evolving marketplace, to see new opportunities and the obstacles that will inevitably present themselves to these opportunities.
What is one thing you hope to learn or discuss with your peers at the forum?
In today’s world of “big talking to big”, i.e. the major distribution companies locking start-ups out with contracts and more red-tape, how will start-ups need to evolve to survive?
What company initiatives are on the horizon for your team in 2017?
Dallen consummated a deal with Zimmer Biomet and our goal now is to expand the product-line and be the best manufacturing partner for them as possible.
What do you believe are the 3 biggest factors impacting the life science industry today?
Lack of capital and lack of a free market, note comment above, overly burdensome regulatory environment.
What are the greatest opportunities for life science companies over the next 5 years?
From a leadership standpoint, where do you draw your inspiration?